We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
关于临床试验性别配额法案的分析。了解谁将从这个1.6万亿美元市场的新规则中受益，以及它将如何改变俄罗斯制药行业。详情请见内文。
